Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.500
+0.030 (2.04%)
At close: Apr 17, 2024, 4:00 PM
1.490
-0.010 (-0.67%)
After-hours: Apr 17, 2024, 6:18 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $80.80 million as of April 17, 2024. Its market cap has decreased by -1.46% in one year.
Market Cap
80.80M
Enterprise Value
10.01M
1-Year Change
-1.46%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $80.80M, a decrease of -47.56%. That is a compound annual growth rate of -9.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 79.20M | -3.88% |
Apr 15, 2024 | 82.40M | -6.68% |
Apr 12, 2024 | 88.30M | -4.13% |
Apr 11, 2024 | 92.10M | 0.55% |
Apr 10, 2024 | 91.60M | 0.66% |
Apr 9, 2024 | 91.00M | 0.55% |
Apr 8, 2024 | 90.50M | 1.80% |
Apr 5, 2024 | 88.90M | -2.31% |
Apr 4, 2024 | 91.00M | -5.60% |
Apr 3, 2024 | 96.40M | -0.62% |
Apr 2, 2024 | 97.00M | 0.62% |
Apr 1, 2024 | 96.40M | 3.99% |
Mar 28, 2024 | 92.70M | -1.70% |
Mar 27, 2024 | 94.30M | 1.18% |
Mar 26, 2024 | 93.20M | 2.42% |
Mar 25, 2024 | 91.00M | -3.50% |
Mar 22, 2024 | 94.30M | 1.18% |
Mar 21, 2024 | 93.20M | -1.69% |
Mar 20, 2024 | 94.80M | -1.15% |
Mar 19, 2024 | 95.90M | 2.90% |
Mar 18, 2024 | 93.20M | -3.32% |
Mar 15, 2024 | 96.40M | 2.88% |
Mar 14, 2024 | 93.70M | 4.81% |
Mar 13, 2024 | 89.40M | 1.59% |
Mar 12, 2024 | 88.00M | -4.56% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AlloVir | 85.10M |
PMV Pharmaceuticals | 84.11M |
Affimed | 83.60M |
Protalix BioTherapeutics | 83.28M |
Eton Pharmaceuticals | 82.60M |
Burning Rock Biotech | 82.10M |
Monogram Orthopaedics | 81.93M |
TRACON Pharmaceuticals | 81.91M |